TempraMed signs five-year Saudi distribution deal with US$3.8 million minimum purchase commitments

• TempraMed signed a five-year Saudi Arabia distribution deal on Aug. 10, 2026 for a private-label VIVI Cap rollout.
• Minimum purchase commitments imply up to USD 3.8 million in aggregate purchases over the term, subject to Saudi regulatory clearance.
• Distributor must place a firm initial purchase order for 10,000 units; 60% becomes payable on regulatory clearance.
• Private-label sales are intended for Nahdi Medical Company’s physical pharmacy network, which operates more than 1,100 locations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608250700NEWSFILECNPR____20260825_311232_1) on August 25, 2026, and is solely responsible for the information contained therein.